Racha Lydia BOUCHOUKA

Dr. Racha Lydia BOUCHOUKA

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2025 in Molecules
Verified
Journal Article
Open access
PDF file
RBRacha Lydia BOUCHOUKA
Racha Lydia BOUCHOUKA
ZKZahia Kabouche
Zahia Kabouche
MDMarie Defondaumière
Marie Defondaumière
MDMarlène Debiossat
Marlène Debiossat
CGCatherine Ghezzi
Catherine Ghezzi
Stefania GarzoliStefania Garzoli
Stefania Garzoli
Stachys duriaei (Lamiaceae) remains unexplored despite its pharmacological potential. In this study, for the first time, the antiproliferative, pro-apoptotic, cell cycle arrest, and vasorelaxant effects of the n-butanolic extract (BESD) and a VLC fraction (BF1SD) of Stachys duriaei were investigated. Antiproliferative activity was evaluated on PC3 and MDA-MB-231 cell lines via MTT assay (72 h). Apoptosis (Annexin V-FITC/PI) and cell cycle arrest (PI/RNase) were assessed by flow cytometry (24 h, 250–1000 µg/mL). Vasorelaxant effects were studied ex vivo on rat aortic rings. LC-HRMS/MS was used for phytochemical analysis. BESD showed higher antiproliferative activity (IC50: 196 ± 6 µg/mL for PC3, 182 ± 8 µg/mL for MDA-MB-231) than BF1SD (IC50: 281 ± 6 µg/mL and 273 ± 3 µg/mL, respectively). Apoptosis was dose-dependent, with BF1SD displaying a stronger effect at 1000 µg/mL (67.3 ± 0.5% vs. 49.9 ± 0.7% for BESD). BESD induced G2/M arrest, while BF1SD caused G0/G1 and G2/M arrest. Vasorelaxation was endothelium-dependent, likely mediated by NO. Identified compounds (hyperoside, luteolin-7-glucoside, and rutin) may contribute to these effects. BESD and BF1SD exhibit anticancer and vasorelaxant properties, indicating potential therapeutic use against cancer and cardiovascular diseases. Further studies are needed to isolate active compounds and confirm their effects in vivo.

22 September 2026 in Chemistry & Biodiversity
Verified
Journal Article
Open access
RBRacha Lydia BOUCHOUKA
Racha Lydia BOUCHOUKA
FLFARIDA LARIT
FARIDA LARIT
ZKZahia Kabouche
Zahia Kabouche
MDMarlène Debiossat
Marlène Debiossat
LRLaurent Riou
Laurent Riou
AKAhmed Kabouche
Ahmed Kabouche
Asphodelus tenuifolius Cav. (Asphodelaceae) is traditionally used in North African ethnomedicine for inflammatory and oxidative stress‐related disorders. In this study, the hydroethanolic root extract was investigated by LC–HRMS/MS, leading to the identification of 58 metabolites, mainly flavonoids, anthraquinones, and cinnamic acid derivatives. Major constituents included luteolin, emodin, luteolin‐7‐ O ‐β‐D‐glucoside, subaphyllin ( N ‐ trans ‐feruloylputrescine), and N‐trans ‐feruloyltyramine. The extract showed moderate antiproliferative activity against MDA‐MB‐231 and PC‐3 cells, while flow cytometry revealed pronounced apoptosis induction (up to 85%) and significant G0/G1 cell‐cycle arrest. Molecular docking and target prediction suggested multitarget modulation of ERα, AR, AKT1, CDK2, and BCL‐2, particularly by aglycone metabolites. ADMET analysis indicated favorable drug‐likeness and safety profiles. These findings provide the first mechanistic evidence supporting the multitarget anticancer potential of A. tenuifolius roots and highlight their value as a source of bioactive anticancer scaffolds.